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Abstract Bone mass differs according to ethnic classifi-
cation, with individuals of African ancestry attaining the
highest measurements across numerous skeletal sites. Ele-
vated bone mass is even maintained in those individuals
exposed to adverse environmental factors, suggesting a
prominent genetic effect that may have clinical or therapeutic
value. Using a candidate gene approach, we investigated
associations of six candidate genes (ESR1, TNFRSF11A,
TNFRSF11B, TNFSF11, SOST and SPP1) with bone mass at
the hip and lumbar spine amongst pre-pubertal black South
African children (mean age 10.6 years) who formed part of
the longitudinal Birth to Twenty cohort. 151 black children
were genotyped at 366 polymorphic loci, including 112
previously associated and 254 tagging single nucleotide
polymorphisms (SNPs). Linear regression was used to
highlight significant associations whilst adjusting for height,
weight, sex and bone area. Twenty-seven markers (8 previ-
ously associated and 19 tag SNPs; P \ 0.05) were found to be
associated with either femoral neck (18) or lumbar spine (9)
bone mineral content. These signals were derived from three
genes, namely ESR1 (17), TNFRSF11B (9) and SPP1 (1).
One marker (rs2485209) maintained its association with the
femoral neck after correction for multiple testing
(P = 0.038). When compared to results amongst Caucasian
adults, we detected differences with respect to associated
skeletal sites. Allele frequencies and linkage disequilibrium
patterns were also significantly different between popula-
tions. Hence, our results support the existence of a strong
genetic effect acting at the femoral neck in black South
African children, whilst simultaneously highlighting possible
causes that account for inter-ethnic bone mass diversity.
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Introduction
Individuals of African ancestry attain a higher average bone
mass (assessed as either bone mineral content [BMC] or bone
mineral density [BMD]) compared to other ethnic groups,
across numerous skeletal sites, specifically when corrected for
covariates [1–3]. This has been documented both in admixed
populations of African Americans and Tobagonian men [4], for
example, as well as amongst non-admixed populations still
resident on the African continent such as Somali women [5]
and black South Africans [6]. This greater bone mass appears to
be established from early childhood [7], implying an important
genetic influence that is in line with strong heritability esti-
mates for BMD (60–90 % in twin studies) [8]. Moreover,
evidence suggests that elevated bone mass in individuals of
African descent is maintained in spite of often numerous
adverse environmental factors. For example, African-Ameri-
can women maintain greater bone mass than white women
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despite a lower mean 25-hydroxyvitamin D concentration [9,
10]. Similarly, data from the National Health and Nutrition
Examination Surveys (NHANES) demonstrated that non-
Hispanic blacks had lower calcium intakes than their white and
Hispanic counterparts [11], likely due to the higher frequency
of lactose intolerance seen amongst black populations [9, 12].
Amongst a cohort of black South African children, partici-
pating in the Birth to Twenty (Bt20) longitudinal study, bone
mass at the femoral neck (FN) was higher than in white children
despite the former having a lower socioeconomic status [6],
lower calcium and vitamin D intakes [13], unfavourable
anthropometric measurements [2, 6, 14] and lower levels of
physical activity [15]. Unravelling the genetic effects respon-
sible for this phenomenon may yield important insights into
bone biology, with possible clinical or therapeutic value.
To date, genetic investigations of bone health have
rarely incorporated children [16]. Attention has usually
been focused on adults, in an effort to identify suscepti-
bility variants for osteoporosis [17–19], however, these
studies tend to be complicated by environmental covariates
that potentially mask associations between genotype and
bone mass. Some have argued that such associations would
be easier to detect during childhood, when genetic regu-
lation of bone is at its peak and environmental influences
have had limited time to exert their effects [16].
The aim of this study was to investigate possible genetic
factors contributing to bone health in black South African
children with a mean age of 10.6 years. With little previous
genetic research for non-admixed Africans, we sought to
interrogate six leading candidate genes known to influence
BMD based on numerous independent studies amongst indi-
viduals of European descent. Specifically, we selected six of
nine candidate genes that maintained significant association to
either lumbar spine (LS) or FN BMD at a meta-analytical level,
according to Richards and colleagues [20]. These included
ESR1 (oestrogen receptor a), TNFRSF11B (osteoprotegerin),
TNFRSF11A (RANK), TNFSF11 (RANKL), SPP1 (osteo-
pontin) and SOST (sclerostin). We hypothesised that whilst
some single nucleotide polymorphic (SNP) markers in these
genes might share significant association to bone mass in both
Europeans and Africans, unique association signals may be
detected in our non-admixed African sample. Such signals
might offer potential clues to the elevated bone mass within
this ethnic group, in addition to further highlighting the dif-
ferences in genetic architecture when compared to Europeans.
Materials and methods
Subjects
Study participants included 151 black children from the Bone
Health sub-cohort (n = 682) of the larger longitudinal Birth
to Twenty cohort in Soweto, South Africa.1 Briefly, the Birth
to Twenty cohort was designed to track the growth and
development of a sample of urban children across their first
20 years of life. Neonates, totalling 3273, were recruited
from public sector hospitals in a 6-week period from April 23
to June 8, 1990, and were assessed annually thereafter.
Numerous environmental and physiological variables were
recorded during each year. The Bone Health sub-cohort was
established 9 years into the study, and selected members
were additionally required to undergo regular dual X-ray
absorptiometry (DXA) scans to track bone mass [14].
Enrolment into the sub-cohort was based on the exclusion
criteria of any pre-existing conditions that would impact on
BMC, including rickets, tuberculosis, cancer, a history of
endocrine disease, gastrointestinal disease associated with
malabsorption, and regular medication use, specifically cor-
ticosteroids, anti-epileptic drugs, calcium and/or vitamin D
supplementation. Since participants were recruited from the
Soweto-Johannesburg metropolitan area, black participants
were all south-eastern Bantu-speakers, belonging to the ‘S’
group according to Guthrie classification [21]. A previous
study in which 18 ancestry informative markers were geno-
typed in 990 black Bt20 participants confirmed that no high-
level population sub-structure was evident. Although
numerous measurements were available, this study only used
bone phenotypic data recorded at a mean age of 10.6 years in
order to avoid complications posed by puberty, such as rapid
growth and bone remodelling that hinders direct comparison
between individuals [16].
Informed consent from a legal guardian was obtained
prior to enrolment into the study. Ethical approval for this
study was granted by the University of the Witwatersrand
Human Research Ethics Committee (Medical); certificate
number M10457.
Anthropometry
Measurements of height, to the last completed 1 mm, were
taken using a wall-mounted stadiometer (Holtain, Cros-
swell, UK), whilst weight, to the nearest completed 0.1 kg,
was recorded using a digital electronic instrument (Dismed,
Halfway House, South Africa) based on standardized pro-
tocols [22]. Both instruments were regularly calibrated, and
subjects wore minimal clothing when being weighed.
Measurement of bone
Measurements of bone area and mineral content at the hip
(FN) and L1 to L4 vertebrae (LS) were performed using the
1 Note that for the purposes of this study, ‘black’ is used to define
individuals of African ancestry without known admixture, whilst
‘white’ denotes individuals of European descent.
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Hologic QDR-4500A DXA machine (Bedford, MA, USA).
Measurements of BMC were assessed and not BMD, as this
has been found to be an inappropriate metric for children
[23]. Using a spinal phantom, the coefficient of variation was
calculated as 0.44 % for BMC (g) and 0.36 % for bone area
(cm2). A single technician conducted all readings to avoid an
additional source of variation. Participants were wearing
only light clothing at the time of measurement.
Sampling of blood and DNA extraction
DNA was extracted from a 5 ml sample of whole blood
using the salting out procedure [24], and stored in Tris/
EDTA (TE) buffer at 4 C. Sample concentrations were
measured using the Tecan Infinite 200 PRO NanoQuant
(Tecan Group Ltd., Ma¨nnedorf, Switzerland) and normal-
ized to 50 ng/ll for the purposes of this study.
SNP selection
Candidate genes were selected based on a recent meta-anal-
ysis conducted by the Genetic Factors for Osteoporosis (GE-
FOS) consortium [20]. Six genes strongly linked to either
LS or FN BMD were selected for validation amongst black
South Africans, namely ESR1, TNFRSF11A, TNFRSF11B,
TNFSF11, SOST and SPP1. A total of 189 SNPs, spanning all
six genes, had been found to generate strong association sig-
nals amongst Europeans (P \ 2.39 9 10-6). Additionally, a
panel of tag SNPs was selected for the purposes of identifying
association signals that may be unique to this population, but
only within genes ESR1, TNFRSF11A, TNFRSF11B, and
TNFSF11 due to kit size limitations. Tagger [25] was used to
identify tag SNPs through a multi-marker tagging approach
with a minor allele frequency of 1 % and an r2 cutoff of 0.8,
among publicly available African data (Yoruba) from the
HapMap data set (Release 27, Phase II ? III, February 2009,
on NCBI B36 assembly, dbSNP b126).
All SNPs were assessed by the Illumina Assay Design
Tool for compatibility with the GoldenGate genotyping
assay. Low scoring SNPs (\0.6 on a scale of 0–1) were
excluded. The final SNP panel consisted of 112 previously
associated and 254 tag SNPs, which provided a cover-
age range of 90–96 % in genes ESR1, TNFRSF11A,
TNFRSF11B, and TNFSF11. Information on these SNPs,
including reference allele designation and allele frequency
amongst different populations was retrieved using Hap-
Mart, an extension of BioMart [26].
Genotyping
Genotyping was performed using the GoldenGate genotyping
assay with VeraCode microbeads on the Illumina BeadX-
pressTM platform (Illumina, USA) as described elsewhere [27].
Quality control
Raw data were examined using the genotyping module of
Beadstudio (Framework version 3.1.3.0; module version
3.2.32). Illumina designed built-in assay controls were used
as a measure of result quality and samples failing more
than two such controls (out of five) were excluded. In terms
of SNP performance, only SNPs with a Hardy–Weinberg
equilibrium (HWE) P value [0.05 were analysed further.
The genotype calls for the remaining SNPs and samples
were individually assessed and ambiguous calls that could
not be clarified were removed.
Data analysis
SAS Enterprise Guide version 4.2 (SAS Institute Inc.,
Cary, NC, USA) was used to assess the descriptive statis-
tics of the cohort. Normality of the distribution for mea-
sured parameters was tested using a Chi-squared test for
goodness-of-fit. Where a normal distribution was applica-
ble, a two-sample t test was conducted in order to detect
differences between participants, sub-divided by gender. In
all other instances, a Wilcoxon–Mann–Whitney test was
used to account for skew distributions. To compare allele
frequencies between populations, a contingency table test
was performed. Quanto (version 1.2.4) [28] was used to
determine the power of the study.
gPLINK software (version 2.050) [29] was used to
perform a linear regression analysis in order to test for
associations between BMC and genotype, using an additive
genetic model. Sex, height, weight and bone area were
entered as covariates, and a label-swapping permutation
procedure (n = 1000) was used to correct for multiple
testing. A significance level threshold of 5 % (a = 0.05)
was adopted for all tests, and P values were rounded-off to
three decimal places.
To further visualise the results for ESR1, LocusZoom
(version 1.1) was used [30] (http://csg.sph.umich.edu/
locuszoom/). These plots are based on data from the
International HapMap Project (Phase II data), the 1000
Genomes Project (August 2009 release), and recent builds




Table 1 shows the descriptive statistics for the study par-
ticipants (n = 151). Values for our sample were not sig-
nificantly different from those reported elsewhere [6] for
the larger bone health sub-cohort of the Bt20 study. When
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considering differences between sex, black boys weighed
significantly less than black girls. With respect to bone
measurements, boys had higher unadjusted BMC at the FN,
but lower BMC at the spine than black girls, prompting the
inclusion of sex as a covariate.
Genotyping
A single SNP (rs9479134) failed to reach quality thresholds
and was removed from further analysis. Twenty additional
SNPs were excluded as their genotype frequencies were
inconsistent with HWE (P \ 0.05). Lastly, 16 SNPs had
[10 % missingness (the proportion of individuals unsuc-
cessfully genotyped for that SNP divided by total study
participants) and were also excluded. The final SNP panel
for analysis consisted of 329 SNPs, out of the 366 initially
chosen.
Association results
Significant associations, prior to multiple testing correc-
tion, are listed in Table 2. All reported beta values indicate
the effect on BMC [measured in grams (g)] with each
additional minor allele, as determined by sample allele
frequencies. Thus, a positive beta value indicates that the
minor allele is associated with increased BMC, whereas a
negative value indicates association with decreased BMC.
Twenty-seven SNPs (8 previously associated; 19 tag)
achieved pointwise estimates for association with BMC
that were significant at the 5 % level, prior to correction.
Nine SNPs were linked to LS BMC and 18 to FN BMC, but
no marker achieved significance for both skeletal sites. The
majority of the associated SNPs were located in either
ESR1 (17) or TNFRSF11B (9), with one signal deriving
from a SNP in SPP1. After adjusting P values for multiple
testing, only one SNP marker (ESR1, rs2485209)
maintained significance at the 5 % level. This marker had
been previously associated to BMD at the LS amongst
Caucasian adults [20]. Given the allele frequency of
rs2485209 within this sample, we were 56 % powered to
detect the effect of this SNP, based on a calculation using
Quanto.
Allele frequencies of all significantly associated SNPs
were contrasted across several populations (Table 2). The
minor allele for rs2485209 is relatively common ([40 %)
in all populations with the exception of the Yoruba popu-
lation (P \ 0.001), showing a highly significant difference
between the two African populations. The potential func-
tional effects of the SNPs were checked using the UCSC
human genome browser (Feb. 2009, GRCh37/hg19
assembly); however, no notable effects were documented
at the time of the study.
ESR1
Due to the number of positive associations, a closer
inspection of ESR1 was conducted. A LocusZoom plot
showing association scores with FN BMC is displayed in
Fig. 1, with r2 measures of linkage disequilibrium (LD)
calculated based on either Yoruba (YRI) or European
(CEU) HapMap population data. rs2485209 is located
towards the 50 end of the gene, within the 150 kb region
upstream of the first coding exon that contains numerous
transcription start sites. Interestingly, this SNP shared little
LD with other typed SNPs in close proximity, according to
Yoruba population data. In contrast, numerous SNPs share
a moderate level of LD with the marker amongst
Europeans.
Discussion
Our modest exploratory study revealed a significant asso-
ciation between rs2485209 and adjusted FN BMC in black
South African children. This marker resides within ESR1,
upstream of the first coding exon, and was previously
detected to influence BMD in adult Caucasians, although at
a different skeletal site (LS). The allele associated with
higher BMC had comparable frequencies between the
current sample and CEU (Utah residents with Northern and
Western European ancestry), CHB (Han Chinese from
Beijing, China) and JPT (Japanese from Tokyo, Japan)
individuals, but notably, it varied across African popula-
tions (0.26–0.44; see Table 2). Limited LD between
rs2485209 and surrounding markers was observed in an
African population (Yoruba, from Nigeria), but appeared
more extensive amongst the European population. A total
of 26 additional SNPs showed promising association with
either FN or LS BMC, prior to correction, and these






Age (years ± SD) 10.53 ± 0.30 10.55 ± 0.30 0.870
Height (cm ± SD) 136.9 ± 6.24 138.8 ± 5.99 0.072
Weight (kg ± SD) 31.74 ± 5.89 34.69 ± 8.17 0.010
FN BMC (g) 3.05 ± 0.36 2.77 ± 0.42 <0.001
FN bone area (cm2) 4.08 ± 0.31 4.01 ± 0.28 0.168
LS BMC (g) 23.46 ± 3.79 25.72 ± 5.64 0.010
LS bone area (cm2) 42.64 ± 4.17 42.95 ± 4.24 0.760
Bone measurements are unadjusted for covariates
Bold values indicate P values that are significant at 5 % level
FN femoral neck, LS lumbar spine, SD standard deviation, cm cen-
timetres, kg kilograms, g grams, cm2 square centimetres
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markers may prove interesting to reassess in a better
powered study. Thus, in line with our hypothesis, we have
replicated an association signal derived from European
research, but have also discovered important differences
that hint at the different genetic regulation of bone mass in
Africans and/or at different ages.
ESR1 is one of the strongest candidate genes known to
influence bone mass, having been replicated in four dif-
ferent study designs [8]. The receptor protein product
mediates the largely beneficial effects of oestrogen on the
maintenance of bone mass in both men and women, as has
been previously documented [31, 32]. Structurally, the
gene displays a complex design [33], possessing eight
coding as well as eight non-coding exons; the latter con-
fined to a 150 kb region at the 50 end, which also contains
two variable number tandem repeats. Each of these non-
coding exons is preceded by an individual promoter
sequence, creating multiple transcription start sites. To
Table 2 List of SNP markers generating significant association signals with bone mineral content in black SA children











Published data (A1 allele frequencies)
YRId CEUd CHB JPT LWK MKK
ESR1 rs11155823 T/G 0.16 0.032 0.469 -0.100 0.06** 0** 0.10 0.09
rs2485209 C/A 0.44 0.002e 0.717 0.112 0.26** 0.41 0.42 0.43 0.36 0.25
rs2504069 G/A 0.23 0.710 0.028 0.864 0.20 0.29 0.07 0.06
rs2982551 C/A 0.42 0.398 0.037 -0.677 0.31** 0.40 0.80 0.82 0.43 0.37
rs3020377 A/G 0.15 0.041 0.401 0.085 0.23 0.70** 0.19 0.21
rs3020396 A/G 0.27 0.013 0.790 0.085 0.20 0.74** 0.38 0.36 0.29 0.41
rs4458702 A/G 0.10 0.037 0.258 -0.129 0.05 0.20** 0.45 0.47 0.07 0.05
rs532010 C/T 0.46 0.033 0.105 -0.065 0.44 0.36* 0.39 0.36 0.33 0.45
rs6910500 A/G 0.07 0.005 0.939 0.174 0.06 0.02* 0 0
rs7744006 A/G 0.13 0.917 0.042 -0.978 0.22* 0** 0 0
rs9322332 C/A 0.45 0.024 0.337 -0.073 0.64** 0.60** 0.61 0.58
rs9340785 C/G 0.05 0.032 0.962 -0.161 0.12* 0** 0 0
rs9340820 G/T 0.16 0.019 0.955 0.095 0.17 0.02** 0.29 0.32 0.28 0.19
rs9340939 A/C 0.13 0.700 0.043 -0.981 0.22* 0.01** 0.03 0 0.16 0.03
rs9371234 A/C 0.17 0.030 0.451 -0.087 0.10 0** 0 0.06
rs9383598 T/C 0.14 0.046 0.791 -0.102 0.06** 0** 0.08 0.08 0.04 0.06
rs9397453 A/G 0.22 0.034 0.406 -0.080 0.08** 0** 0.08 0.08 0.10 0.12
SPP1
TNFRSF11B
rs2869722 G/A 0.15 0.030 0.446 0.101 0.12 0.33** 0.26 0.23
rs1032129 C/A 0.33 0.466 0.050 0.712 0.42 0.32 0.57 0.65
rs11573938 A/G 0.02 0.022 0.886 0.317 0.06* 0.14** 0.06 0 0.04 0.07
rs1804854 C/T 0.33 0.373 0.036 -0.761 0.28 0** 0 0 0.33 0.21
rs4520195 G/A 0.27 0.200 0.014 -0.977 0.23 0** 0 0 0.28 0.11
rs7464496 T/C 0.06 0.046 0.946 0.141 0.06 0.55** 0.36 0.22
rs882763 T/C 0.33 0.356 0.030 -0.790 0.29 0** 0 0 0.33 0.21
rs2035977 G/C 0.42 0.015 0.100 0.088 0.44 0.57** 0.44 0.38
rs2101752 G/T 0.23 0.056 0.027 0.925 0.21 0.56** 0.36 0.25
rs7839059 C/A 0.33 0.036 0.208 0.074 0.35 0.67** 0.80 0.76
MAF minor allele frequency, YRI Yoruba from Ibadan, Nigeria; CEU Utah residents with Northern and Western European ancestry, CHB Han
Chinese from Beijing, China, JPT Japanese from Tokyo, Japan, LWK Luhya from Webuye, Kenya, MKK Maasai from Kinyawa, Kenya
Bold values indicate P values that are significant at 5 % level
* P \ 0.05, ** P \ 0.01
a Minor (effect) allele
b Listed P values are those prior to correction for multiple testing
c Effect of each added minor allele on BMC (g) at skeletal sites with significant association. Negative values indicate a decrease in bone mass,
whilst positive values indicate an increase
d HapMap allele frequency data for these populations were compared to the current study using a contingency table test
e P value after correction was 0.038
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date, ESR1 is known to encode 17 different transcripts
(Ensembl release 65). Although the function of these has
been difficult to investigate [34], variation near the 50 end
of ESR1 has significant potential to impact on the expres-
sion of one or more transcripts, with downstream conse-
quences for bone health.
Interestingly, rs2485209 is located within the 150 kb
stretch of non-coding exons and their individual promoters.
With links to different skeletal sites between our sample of
black children (FN) and Caucasian adults (LS), there exists
the possibility of two separate causal variants being tagged
by this SNP. LD differences between Yoruba and European
populations lend further support to this line of reasoning
(Fig. 1). Although experimental confirmation is required,
we speculate that this region of the gene may, in general,
offer valuable insight into observed differences in inter-
ethnic bone mass, and should be prioritised in future
research. Discrepancies in associated skeletal sites might
Fig. 1 LocusZoom plots for femoral neck association results within
ESR1. The SNP marker with the leading association signal
(rs2485209; P = 0.038 after correction for multiple testing) is
coloured purple, with other SNP markers coloured according to the
strength of r2 linkage disequilibrium (LD) shared with the leading
marker, based on Yoruba population data. rs2485209 maps to the
150 kb region upstream of the first coding exon, which contains
several non-coding exons that have unique, individual promoters.
Only one other marker is reported to share moderate (0.4–0.6) linkage
disequilibrium with the leading SNP. The inset diagram shows the
same results, but LD is calculated using data from European ancestry
individuals. Here, rs2485209 is in moderate LD with numerous other
markers. These fall between successive peaks of the blue line graph
that measure, on the second y-axis, the recombination frequency
during meiosis (colour figure online)
J Bone Miner Metab (2013) 31:708–716 713
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also speak to genetic differences in bone regulation
between childhood and adulthood, and/or between different
skeletal sites, with some having argued that gene sets
responsible for bone maintenance may differ by site and
with age [35, 36].
Although failing to maintain significance, we briefly
consider the 26 other markers that were associated to BMC
prior to correction, as the false negative rate is suspected to
be high given a small sample size. Amongst these markers
are seven other previously associated SNPs, based on the
GEFOS meta-analysis (Table 3). In addition to rs2485209,
three of these seven tended towards an association with a
different skeletal site than in Caucasian adults. Further-
more, five SNPs displayed statistically significant allele
frequency differences between our sample and European
individuals including rs2869722, rs7464496, rs2035877,
rs2101752 and rs7939059 (see Table 2). Effect size com-
parisons were not made, as the unit of measurement dif-
fered between studies (BMC versus BMD) as well as the
average age of participants (10.6 years versus [49 years).
Of the 19 remaining markers, these appeared to strengthen
the importance of ESR1 and TNFRSF11B over other can-
didate genes, within this sample. Similarly, associations
appeared more often at the FN; the skeletal site at which
bone mass differences appear to be greatest between black
and white South Africans [37, 38].
Several important limitations of this study need to be
borne in mind. Most importantly, we lacked a suitable
comparison for our study. To our knowledge, the only
genome-wide publication on genetic contributions to bone
phenotypes in 10-year-old children was that of Duren and
colleagues [39]. They performed a search for loci linked to
metacarpal thickness in 10-year-old children participating
in the Fels Longitudinal Study. Although age-matched, the
study investigated both a different phenotype and skeletal
site, and the subsequent association signals did not map to
the vicinity of ESR1. Thus, without sufficient research on
the genetic mechanisms underpinning childhood bone
health, we cannot fully clarify whether our results speak to
the genetic factors that are important for Africans, or for
children. Furthermore, the limited sample size meant we
were substantively underpowered. BMC measurements
were not all obtained within the same season, and thus may
be subject to seasonal variances [40], although this was not
suspected to be a major concern based on previous research
[41]. Of the 37 SNPs failing quality control 27 were tag
SNPs, causing a loss of coverage in genes ESR1,
TNFRSF11B, TNFRSF11A and TNFSF11. The remaining
ten markers were previously associated SNPs that would
need to be retested to ascertain their validity to this pop-
ulation. We only tested for associations under an additive
model, possibly missing out on dominant and recessive
effects. Lastly, there is a current lack of consensus on the
best method to correct BMC for covariates, with each
corrective method producing different results [6, 42].
Based on our modest yet promising results, future
genetic research into the bone mass of individuals of
African ancestry should be encouraged. Results from a
larger sample size may afford insight into a number of
smaller effect sizes across a broader range of genes, as well
as possible sex-specific effects [43, 44], which we were
unable to investigate here. Moreover, evidence may accu-
mulate to support the theory of a genetic ‘set-point’ for
bone mass [45, 46], which is currently a highly feasible
explanation for the bone mass observed in black Bt20
members, despite so many adverse environmental effects.
Replication studies amongst separate African population
groups, however, should also be prioritised to help validate
findings and investigate possible local, population-specific,
environmental factors [47].
In conclusion, we have provided the first glimpse into
the genetic factors regulating the elevated bone mass of
African individuals. These results support the importance
of both ESR1 and TNFRSF11B as candidate genes that
Table 3 Comparison between present study results and those from the GEFOS meta-analysis
Gene SNP ID South Africa GEFOS meta-analysis [20]
Allele P value Skeletal site Allele P valuea Skeletal site
ESR1 rs2485209 C 0.002 FN C 3.20E-07 LS
rs2504069 G 0.028 LS G 1.10E-08 LS
rs2982551 C 0.037 LS C 2.10E-09 LS
SPP1
TNFRSF11B
rs2869722 G 0.030 FN G 9.60E-07 LS
rs7464496 T 0.046 FN C 1.70E-09 LS
rs2035977 G 0.015 FN C 6.40E-08 LS
rs7839059 C 0.036 FN A 4.50E-08 FN
rs2101752 G 0.027 LS T 5.00E-08 LS
FN femoral neck, LS lumbar spine
a P value determined under a fixed effects model
714 J Bone Miner Metab (2013) 31:708–716
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influence bone mass. However, SNP allele frequency dif-
ferences, LD dissimilarities and discordance of associated
skeletal sites provide important signs of the influence
genetic variation may have in creating bone mass diversity,
specifically between Europeans and Africans.
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